Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

TUMORICIDAL ACTIVITY OF BENZOQUINONOID ANSAMYCINS AGAINST PROSTATE CANCER AND OTHER PRIMITIVE NEURAL MALIGNANCIES

  • Read more about TUMORICIDAL ACTIVITY OF BENZOQUINONOID ANSAMYCINS AGAINST PROSTATE CANCER AND OTHER PRIMITIVE NEURAL MALIGNANCIES
US Application 07/961,250
Filed on 1992-10-14

IMPROVED POLYETHYLENE GLYCOL (PEG) REAGENT

  • Read more about IMPROVED POLYETHYLENE GLYCOL (PEG) REAGENT
US Patent 4,650,909
Filed on 1985-10-29

IMPROVED POLYETHYLENE GLYCOL (PEG) REAGENT

  • Read more about IMPROVED POLYETHYLENE GLYCOL (PEG) REAGENT
US Application 06/675,617
Filed on 1984-11-28

IMPROVED POLYETHYLENE GLYCOL (PEG) REAGENT

  • Read more about IMPROVED POLYETHYLENE GLYCOL (PEG) REAGENT
US Application 06/545,522
Filed on 1983-10-26

CONSTRUCTS ENCODING RECOMBINANT ANTIBODY-TOXIN FUSION PROTEINS

  • Read more about CONSTRUCTS ENCODING RECOMBINANT ANTIBODY-TOXIN FUSION PROTEINS
US Patent 6,051,405
Filed on 1992-04-08

USE OF 8-Cl-CAMP AS ANTICANCER DRUG

  • Read more about USE OF 8-Cl-CAMP AS ANTICANCER DRUG
US Application 07/896,452
Filed on 1992-06-04

TEST FOR OCCULT BLOOD IN AN EMULSIFIED AQUEOUS/ORGANIC SYSTEM

  • Read more about TEST FOR OCCULT BLOOD IN AN EMULSIFIED AQUEOUS/ORGANIC SYSTEM
US Patent 4,035,150
Filed on 1976-07-07

SEPARATION OF TRIPHENYLPHOSIPHINE OXIDE FROM METHOTREXATE ESTER AND PURIFICATION OF SAID ESTER

  • Read more about SEPARATION OF TRIPHENYLPHOSIPHINE OXIDE FROM METHOTREXATE ESTER AND PURIFICATION OF SAID ESTER
US Patent 4,421,913
Filed on 1981-12-11

MONOCLONAL ANTIBODY (D612) HAVING SELECTIVE REACTIVITY FOR GASTROINTESTINAL CARCINOMAS AND METHODS FOR EMPLOYING THE SAME.

  • Read more about MONOCLONAL ANTIBODY (D612) HAVING SELECTIVE REACTIVITY FOR GASTROINTESTINAL CARCINOMAS AND METHODS FOR EMPLOYING THE SAME.
US Application 08/012,212
Filed on 1993-02-02

CELL CULTURE MEDIUM FOR HUMAN LIVER EPITHELIAL CELL LINE

  • Read more about CELL CULTURE MEDIUM FOR HUMAN LIVER EPITHELIAL CELL LINE
US Patent 5,342,777
Filed on 1992-03-03

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1616
  • Page 1617
  • Page 1618
  • Page 1619
  • Page 1620
  • Page 1621
  • Page 1622
  • Page 1623
  • Page 1624
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health